Emerging trends and New Drugs

The aim of the TREND scheme, which was established in 1999, is to provide information about illegal drug use and users, and on emerging phenomena. Emerging phenomena refer either to new phenomena or to existing phenomena that have not yet been detected by other observation systems.

TREND relies on a network of eight local coordinating sites (Bordeaux, Lille, Lyon , Marseille, Metz, Paris, Rennes, Toulouse) with a common information collection  and  analysis  strategy.  The  data  collection  tools  used  are  mainly  qualitative: continuous ethnographic observations conducted in urban areas and  on  the  party  scene,  questionnaires  are  administered  to  structures  or  associations in contact with drug users, focus groups (“health”, “law enforcement”)  that  aim  to  rapidly  establish  overviews  of  the  situation  with  professionals in the field.

TREND also relies on:

  • SINTES  (National  Detection  System  of  Drugs  and  Toxic  Substances),  an  observation  system  geared  towards  detecting  and  analysing  the  composition of illegal substances on the national territory;
  • the monitoring of virtual spaces and NPS;
  • recurrent  quantitative  surveys,  such  as  the  ENa-CAARUD  survey  among  drug users seen in French low-threshold structures certified as CAARUDs;
  • information  systems  supervised  by  the  CEIPs  (Centres  for  evaluation  and  information  on  pharmacodependence)  and  the  ANSM  (National  Agency  for  Medicines  and  Health  Products  Safety),  the  OCRTIS  (Central  office  for  the  repression of drug-related offences) and the INPS (National forensic science institute) and finally, other OFDT surveys.

While   these   investigations   reflect   realities   from  the  field  that  are  mainly  confined  to  metropolitan  areas,  the  TREND  scheme  also  carries  out  investigations that analyse changes in use in various contexts (rural areas, counties overseas,  working-class  areas,  etc.),  thanks  in  particular  to  the  financial  support  from  the  Île-de-France,  Auvergne-Rhônes-Alpes  and  Indian  Ocean  regional  health  agencies  (ARS)  and  as  of  2019,  the  Provence-Alpes-Côte  d’Azur and Hauts-de-France ARS.


Psychoactive substances, users and markets: recent trends (2016-2017)
Tendances N° 129, December 2018

Psychoactive substances, users and markets: recent trends (2016-2017)
Tendances N° 121, December 2017

Psychoactive substances, users and markets: recent trends (2015-2016)
Tendances N° 115, December 2016

Psychoactive substance use in France: recent trends (2014-2015)
Tendances N° 106, December 2015

Illegal or misused substances: recent trends (2013-2014)
Tendances N° 96, December 2014

Use of Ketamine in France: recent trends (2012-2013)
Brief, June 2014

Markets, products, users: recent trends (2011-2012)
Tendances N° 86, July 2013

Noteworthy phenomena and emerging trends in illegal drugs (2010-2011)
Tendances N° 78, February 2012

Illegal Drugs: the 2009 observations of the TREND system
Tendances N° 73, December 2010

The eight national report from the TREND system
Tendances N° 58, February 2008

Cocaine small-scale dealing in France
Tendances N° 53, April 2007

The seventh national report on the TREND system
Tendances N° 52, December 2006

Recent trends and new drugs in France - The results of the sixth national report on the TREND system : subject-based operations 2000-2004 and principal observations 2004
Tendances N° 45, December 2005

Recent trends and new drugs in France in 2002 - Results of the fourth national report
Tendances N° 31, July 2003

Emerging phenomena linked to the use of drugs in France in 2001
Tendances N° 23, July 2002

Emerging phenomena linked to drug use
Tendances N° 15, July 2001

Drugs in Europe

2023 EMCDDA European Drug Report

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.

  Statistical Bulletin 2023

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.